Komlossy Law, P.A. Announces Investigation of Astex Pharmaceuticals, Inc.

HOLLYWOOD, Fla.--(BUSINESS WIRE)--Komlossy Law, P.A. is investigating the Board of Directors of Astex Pharmaceuticals, Inc. (“Astex”) or the “Company”) (NASDAQ:ASTX) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to complete a sale of the Company to Otsuka Pharmaceutical ("Otsuka") in a transaction valued at approximately $886 million. Pursuant to the terms of the proposed transaction, Astex shareholders are to receive $8.50 for each share of the Company.